CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes

dc.contributor.authorSchnell, Oliver
dc.contributor.authorBattelino, Tadej
dc.contributor.authorBergenstal, Richard
dc.contributor.authorBirkenfeld, Andreas L.
dc.contributor.authorCeriello, Antonio
dc.contributor.authorCheng, Alice
dc.contributor.authorDavies, Melanie
dc.contributor.authorEdelman, Steve
dc.contributor.authorForst, Thomas
dc.contributor.authorGiorgino, Francesco
dc.contributor.authorGreen, Jennifer
dc.contributor.authorGroop, Per\\-Henrik
dc.contributor.authorHadjadj, Samy
dc.contributor.authorHeerspink, Hiddo J. L.
dc.contributor.authorHompesch, Marcus
dc.contributor.authorIzthak, Baruch
dc.contributor.authorJi, Linong
dc.contributor.authorKanumilli, Naresh
dc.contributor.authorMankovsky, Boris
dc.contributor.authorMathieu, Chantal
dc.contributor.authorMiszon, Martin
dc.contributor.authorMustafa, Reem
dc.contributor.authorNauck, Michael
dc.contributor.authorPecoits\\-Filho, Roberto
dc.contributor.authorPettus, Jeremy
dc.contributor.authorRanta, Kari
dc.contributor.authorRodbard, Helena W.
dc.contributor.authorRossing, Peter
dc.contributor.authorRyden, Lars
dc.contributor.authorSchumm\\-Draeger, Petra\\-Maria
dc.contributor.authorSolomon, Scott D.
dc.contributor.authorSkrha, Jan
dc.contributor.authorTopsever, Pinar
dc.contributor.authorVilsboll, Tina
dc.contributor.authorWilding, John
dc.contributor.authorStandl, Eberhard
dc.date.accessioned2025-10-16T15:15:45Z
dc.date.issued2023
dc.identifier.doi10.1186/s12933-023-01788-6
dc.identifier.otherWOS:000954649400001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6529
dc.publisherBMC
dc.sourceCARDIOVASCULAR DIABETOLOGY
dc.subjectCardiovascular disease
dc.subjectChronic kidney disease
dc.subjectDiabetes
dc.subjectGIP
dc.subjectGLP\\-1 receptor agonist
dc.subjectHeart failure
dc.subjectObesity
dc.subjectSGLT2 inhibitor
dc.titleCVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
dc.typeEditorial Material

Dosyalar

Koleksiyonlar